Empagliflozin was found to be associated with a lower combined risk for cardiovascular death or hospitalization for heart failure compared with placebo in patients receiving recommended therapy for heart failure.
An abridged version of the REVEAL risk calculator, the REVEAL Lite 2, represents a simpler and accurate tool for predicting mortality risk in patients with pulmonary arterial hypertension.
Among some patients with cancer-associated thrombosis, rivaroxaban may be a viable alternative to low-molecular-weight heparin.
Patients with HFpEF have substantial exercise intolerance, which may be due to peripheral factors.
A 4-step protocol was found to accurately and efficiently identify patients with STEMI who can be safely discharged after successful primary PCI.
Quality of care and in-hospital mortality were found to be comparable for patients with heart failure who were covered by Medicare Advantage or fee-for-service Medicare.
In a European study, approximately one-third of hospitalizations involving patients with recurrent hyperkalemia directly related to serum potassium elevation.
Supplementation with eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) is associated with a reduced risk for myocardial infarction (MI) and coronary heart disease (CHD) events.
Clinical outcomes of patients with heart failure were found to correlate with alterations in the levels of a set of biomarkers.
ACC releases recommendations regarding the use of coronary CTA as an initial tool for the diagnosis of stable coronary artery disease.
Intensive blood pressure lowering to improve cardiovascular outcomes in patients with hypertension is supported by evidence.
Researchers evaluated the prevalence of abdominal aortic calcification and its association with prevalent vertebral fractures in women with rheumatoid arthritis.
Severe obesity in organ donors is not associated with adverse heart transplant outcomes.
Risk models routinely used for predicting 30-day mortality risk after TAVR were found to have mediocre discrimination performance.
Researchers evaluated the association between osteoporosis and vertebral fragility fractures with cardiovascular calcification in patients with chronic obstructive pulmonary disease.
Coronary microvascular dysfunction was found to be independently associated with hospitalization for heart failure and cardiovascular death in patients with chronic stable HFpEF.
Oral combination therapy does not appear to help achieve or maintain low risk status in most treatment-naive patients with pulmonary arterial hypertension.
Researchers analyzed whether hypertension onset occurs at an earlier age in individuals with multiple sclerosis who were born post-1965.
Higher doses of renin angiotensin system blockade were found to be associated with improved survival and beneficial left ventricular remodeling 3 years after transcatheter aortic valve replacement.
Multichannel smartwatch ECG were found to be in agreement with standard ECGs for the detection of ST-segment changes in patients with acute coronary syndrome.